American Company Developing Vaccine That Targets New Omicron COVID-19 Variant
An American biotechnology company is devloping a version of its COVID-19 vaccine that specifically targets the newly identified variant of the virus – Omicron. Maryland-based Novavax has already started developing the version, with plans to start testing it next month. The updated formulation revolves around a new spike protein, which triggers a response from the … Read more